Close
Nordic 9Nordic 9

BBK (investor - Others)

Spain bbk.eus
See something wrong or missing? Let us know
Offices:Bilbao

BBK is a private organisation holding 57% of the equity of Kutxabank, and also helps shore up the local economy by investing in businesses.

Average round investment:8.19M USD
Average number per year:1.0
Distribution: 2020 (1)2019 (1)
Portfolio companies: Spain BeGasSpain Oncomatryx
Mostly invests in: Spain Spain (2) Transportation (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to BBK

Name Criteria
Spain Ekarpen
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Transportation, Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Repsol
77%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Transportation, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Sweden Briban Invest
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Transportation, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Epidarex Capital
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Groupe IRD
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Merieux Equity Partners
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Robin Tombs
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Taiho Ventures
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway RadForsk
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Jonas Sjögren
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top